A Study of MHB048C in Patients With Advanced Solid Tumors

Summary

This is a first-in-human, open-label, multicenter Phase I/II study of MHB048C in patients with advanced solid tumors. The study was designed to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of MHB048C monotherapy.

Timeline

Start

2026-01-16

Primary completion

2029-10

Completion

2029-10

Drugs

Indications